Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation
Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation: a Prospective Cohort Study
Sponsor: Chen Xiaoping
A NA clinical study on Hepatocellular Carcinoma, this trial is actively recruiting participants. The trial is conducted by Chen Xiaoping and has accumulated 6 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Jan 2026 — Present [monthly]
Recruiting NA
-
Sep 2025 — Jan 2026 [monthly]
Recruiting NA
-
Sep 2024 — Sep 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Mar 2024 — May 2024 [monthly]
Recruiting NA
First recorded
Dec 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chen Xiaoping
For direct contact, visit the study record on ClinicalTrials.gov .